Market Performance
Charles River Laboratories (CRL) surged 9.33 % during the 24‑hour period that concluded at 11:51 AM Central Europe on Thursday, 22 September 2026. The stock trades at approximately USD 344.87 on major exchanges, with a circulating supply of 47.7 million shares. The company’s market capitalisation stands at USD 16.5 billion, and roughly USD 946.5 million of CRL shares were exchanged over the last day, underscoring robust liquidity. Since the end of the previous month, the stock has appreciated by 20.96 %, reflecting sustained investor confidence.
The 200‑day simple moving average is currently at USD 216.85, providing a historical benchmark against which the recent rally can be measured. Within the past 52 weeks, the highest price reached USD 348.95 on 21 October 2026, while the lowest point was USD 146.20 on 19 May 2026, illustrating a substantial upside potential over the year.
Recent Corporate Disclosure
On 22 September 2026, Charles River Laboratories filed a Rule 144 notification with the U.S. Securities and Exchange Commission. The filing revealed that Officer Shannon M. Parisotto exercised stock options, purchased common shares on the New York Stock Exchange, and subsequently sold several thousand shares in August and early October of the same year. The proceeds from these transactions, while modestly lower than earlier sales, did not materially affect the company’s share price. The disclosure further highlighted that Officer Parisotto’s transactions were governed by the 2026 employee‑stock‑purchase plan adopted earlier that year. No additional corporate actions or significant operational changes were reported.
Comparative Performance of Peer Stocks
| Ticker | 24‑Hour Change | Current Price (USD) | Market Capitalisation (USD bn) | P/E Ratio |
|---|---|---|---|---|
| OVV (Ovintiv) | –0.61 % | 69.86 | 19.4 | 20.27 |
| TOST (Toast) | –0.34 % | 32.54 | 18.9 | 41.76 |
| BG (Bunge Global) | –0.75 % | 102.23 | 19.4 | 19.99 |
| SNA (Snap‑on) | +0.68 % | 368.91 | 19.0 | 18.73 |
| WWD (Woodward) | +0.33 % | 325.15 | 19.1 | 36.21 |
While several peers experienced modest declines, Snap‑on and Woodward displayed slight gains, suggesting a mixed sentiment within the industrial and materials sectors.
Company Overview
Charles River Laboratories International, Inc., headquartered in Wilmington, United States, operates in the healthcare sector, offering research tools and support services for drug discovery and development. Its core competency lies in providing animal research models for new drugs, devices, and therapies, catering to pharmaceutical and biotechnology firms, hospitals, and academic institutions worldwide. Listed on the New York Stock Exchange, the company went public on 23 June 2000. Further information on its portfolio and services can be found at www.criver.com .
